Other Income/Expenses (Net)

-$1.26B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported-$1.26Bperiod endingJun 30, 2026

TEVA TTM Other Income/Expenses (Net) (-$48.20M → -$1.26B)

TTM Other Income/Expenses (Net)

High-resolution chart · PNG

TEVA other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	4,299,000
Mar 31, 2001	-36,182,000
Dec 31, 2000	-36,544,000
Sep 30, 2000	-75,944,000
Jun 30, 2000	-83,591,000
Mar 31, 2000	-40,514,000
Dec 31, 1999	-36,780,000
Sep 30, 1999	-62,502,000
Jun 30, 1999	-47,260,000
Mar 31, 1999	-45,420,000
Dec 31, 1998	-45,000,000
Sep 30, 1998	-9,800,000
Jun 30, 1998	-4,400,000
Mar 31, 1998	-2,900,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	-250,200,000
Dec 31, 1996	-250,200,000
Sep 30, 1996	-250,200,000
Jun 30, 1996	-250,200,000
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	192,300,000
Jun 30, 1992	113,600,000
Mar 31, 1992	35,800,000
Dec 31, 1991	-51,500,000
Sep 30, 1991	-95,000,000
Jun 30, 1991	-78,900,000
Mar 31, 1991	-70,700,000
Dec 31, 1990	-49,100,000
Sep 30, 1990	-46,300,000
Jun 30, 1990	-47,500,000
Mar 31, 1990	-46,700,000
Dec 31, 1989	-49,200,000
Sep 30, 1989	-78,600,000
Jun 30, 1989	-61,400,000
Mar 31, 1989	-42,700,000
Dec 31, 1988	-24,500,000
Sep 30, 1988	-175,200,000
Jun 30, 1988	-155,000,000
Mar 31, 1988	-139,800,000
Sep 30, 1987	-124,700,000
Jun 30, 1987	-131,100,000
Dec 31, 1986	-48,200,000
Sep 30, 1986	-36,100,000
Jun 30, 1986	-24,000,000